Health
Researchers study red-light therapy for brain injuries, citing preliminary trials
Slashdot reports that University of Utah scientists are evaluating photobiomodulation therapy, though definitive trials remain pending.
The short version
- University of Utah researchers are studying photobiomodulation therapy to determine if it can protect neurological health and treat brain injuries.[Slashdot]
- A study published in the Journal of Neurotrauma observed 26 BYU football players over a season to test the therapy's effects.[Slashdot]
- Researchers cite 14 peer-reviewed studies linking the treatment to improvements in mood, cognition, and motor performance.[Slashdot]
- Definitive clinical trials have not yet been conducted, and some medical experts remain skeptical.[Slashdot]
Key facts
- University of Utah researchers are examining medical-grade photobiomodulation therapy to evaluate its effects on brain injuries.[Slashdot]
- A seasonal study involving 26 BYU football players was published in the Journal of Neurotrauma.[Slashdot]
- Researchers state that 14 peer-reviewed studies have tied the therapy to gains in cognitive, mood, and motor functions.[Slashdot]
What remains uncertain
- Definitive clinical trials have not yet taken place, broader validation is needed, and some specialists in the field remain skeptical.[Slashdot]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.